3TTZ
Crystal structure of a topoisomerase ATPase inhibitor
Summary for 3TTZ
Entry DOI | 10.2210/pdb3ttz/pdb |
Related | 3U2D 3U2K |
Descriptor | DNA gyrase subunit B, 2-[(3S,4R)-4-{[(3,4-dichloro-5-methyl-1H-pyrrol-2-yl)carbonyl]amino}-3-fluoropiperidin-1-yl]-1,3-thiazole-5-carboxylic acid, MAGNESIUM ION, ... (4 entities in total) |
Functional Keywords | protein-inhibitor complex, atp-binding, structure-based drug design, antimicrobial, isomerase-isomerase inhibitor complex, isomerase/isomerase inhibitor |
Biological source | Staphylococcus aureus More |
Cellular location | Cytoplasm : P0A0K8 |
Total number of polymer chains | 2 |
Total formula weight | 46054.51 |
Authors | Boriack-Sjodin, P.A.,Read, J.,Eakin, A.E.,Sherer, B.A. (deposition date: 2011-09-15, release date: 2011-11-16, Last modification date: 2024-02-28) |
Primary citation | Sherer, B.A.,Hull, K.,Green, O.,Basarab, G.,Hauck, S.,Hill, P.,Loch, J.T.,Mullen, G.,Bist, S.,Bryant, J.,Boriack-Sjodin, A.,Read, J.,Degrace, N.,Uria-Nickelsen, M.,Illingworth, R.N.,Eakin, A.E. Pyrrolamide DNA gyrase inhibitors: Optimization of antibacterial activity and efficacy. Bioorg.Med.Chem.Lett., 21:7416-7420, 2011 Cited by PubMed: 22041057DOI: 10.1016/j.bmcl.2011.10.010 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (1.63 Å) |
Structure validation
Download full validation report